145 related articles for article (PubMed ID: 2991580)
41. Effect of anticellular serum on the attachment of enteroviruses to HeLa cells.
Axler DA; Crowell RL
J Virol; 1968 Aug; 2(8):813-21. PubMed ID: 4302746
[TBL] [Abstract][Full Text] [Related]
42. Purification of the Sabin strain of poliovirus type I through treatment with sarkozyl.
Fiszman M; Bucchini D; Girard M
J Virol; 1971 May; 7(5):687-9. PubMed ID: 4326754
[TBL] [Abstract][Full Text] [Related]
43. Molecular weight of poliovirus ribonucleic acid.
Granboulan N; Girard M
J Virol; 1969 Oct; 4(4):475-9. PubMed ID: 4309881
[TBL] [Abstract][Full Text] [Related]
44. A mutation in VP4 defines a new step in the late stages of cell entry by poliovirus.
Moscufo N; Yafal AG; Rogove A; Hogle J; Chow M
J Virol; 1993 Aug; 67(8):5075-8. PubMed ID: 8392631
[TBL] [Abstract][Full Text] [Related]
45. Specificity of coxsackievirus B3 interaction with human, but not murine, decay-accelerating factor: replacement of a single residue within short consensus repeat 2 prevents virus attachment.
Pan J; Zhang L; Organtini LJ; Hafenstein S; Bergelson JM
J Virol; 2015 Jan; 89(2):1324-8. PubMed ID: 25392210
[TBL] [Abstract][Full Text] [Related]
46. A comparison of genomic homologies among the coxsackievirus B group: use of fragments of the cloned coxsackievirus B3 genome as probes.
Tracy S
J Gen Virol; 1984 Dec; 65 ( Pt 12)():2167-72. PubMed ID: 6096493
[TBL] [Abstract][Full Text] [Related]
47. Coxsackieviral proteins functionally recognize the polioviral cloverleaf structure of the 5'-NTR of a chimeric enterovirus RNA: influence of species-specific host cell factors on virus growth.
Zell R; Klingel K; Sauter M; Fortmüller U; Kandolf R
Virus Res; 1995 Dec; 39(2-3):87-103. PubMed ID: 8837877
[TBL] [Abstract][Full Text] [Related]
48. Infectivity and sedimentation of rhinovirus ribonucleic acid.
Nair CN; Lonberg-Holm KK
J Virol; 1971 Feb; 7(2):278-80. PubMed ID: 4329400
[TBL] [Abstract][Full Text] [Related]
49. Elution and uncoating of Coxsackievirus B3 by isolated HeLa cell plasma membranes.
Roesing TG; Toselli PA; Crowell RL
J Virol; 1975 Mar; 15(3):654-7. PubMed ID: 123011
[TBL] [Abstract][Full Text] [Related]
50. Cleavage of Grb2-Associated Binding Protein 2 by Viral Proteinase 2A during
Deng H; Fung G; Qiu Y; Wang C; Zhang J; Jin ZG; Luo H
Front Cell Infect Microbiol; 2017; 7():85. PubMed ID: 28361043
[TBL] [Abstract][Full Text] [Related]
51. Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency.
Feuer R; Mena I; Pagarigan RR; Hassett DE; Whitton JL
Med Microbiol Immunol; 2004 May; 193(2-3):83-90. PubMed ID: 12925877
[TBL] [Abstract][Full Text] [Related]
52. Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent.
Esfandiarei M; Luo H; Yanagawa B; Suarez A; Dabiri D; Zhang J; McManus BM
J Virol; 2004 Apr; 78(8):4289-98. PubMed ID: 15047842
[TBL] [Abstract][Full Text] [Related]
53. IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication.
Fairweather D; Yusung S; Frisancho S; Barrett M; Gatewood S; Steele R; Rose NR
J Immunol; 2003 May; 170(9):4731-7. PubMed ID: 12707353
[TBL] [Abstract][Full Text] [Related]
54. In vitro protein synthetic activity of membrane-bound poliovirus polyribosomes.
Roumiantzeff M; Summers DF; Maizel JV
Virology; 1971 May; 44(2):249-58. PubMed ID: 4327715
[No Abstract] [Full Text] [Related]
55. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus.
Martino TA; Petric M; Weingartl H; Bergelson JM; Opavsky MA; Richardson CD; Modlin JF; Finberg RW; Kain KC; Willis N; Gauntt CJ; Liu PP
Virology; 2000 May; 271(1):99-108. PubMed ID: 10814575
[TBL] [Abstract][Full Text] [Related]
56. A plasma membrane component able to bind and alter virions of poliovirus type 1: studies on cell-free alteration using a simplified assay.
Guttman N; Baltimore D
Virology; 1977 Oct; 82(1):25-36. PubMed ID: 197703
[No Abstract] [Full Text] [Related]
57. Identification and characterization of the cell surface 70-kilodalton sialoglycoprotein(s) as a candidate receptor for encephalomyocarditis virus on human nucleated cells.
Jin YM; Pardoe IU; Burness AT; Michalak TI
J Virol; 1994 Nov; 68(11):7308-19. PubMed ID: 7933115
[TBL] [Abstract][Full Text] [Related]
58. Coxsackie B virus and its interaction with permissive host cells.
Selinka HC; Huber M; Pasch A; Klingel K; Aepinus C; Kandolf R
Clin Diagn Virol; 1998 Apr; 9(2-3):115-23. PubMed ID: 9645993
[TBL] [Abstract][Full Text] [Related]
59. New poliovirus-related polypeptides in the nucleus-associated fraction of HeLa cell cytoplasm.
Berghe DV
Biochem Biophys Res Commun; 1973 Feb; 50(3):957-63. PubMed ID: 4347534
[No Abstract] [Full Text] [Related]
60. [Study on the biological properties of solubilized HeLa cell receptors for group B coxsackieviruses].
Xu R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Feb; 12(1):13-8. PubMed ID: 2161293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
